Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Revolution Medicines (RVMD) Retained Earnings: 2019-2024

Historic Retained Earnings for Revolution Medicines (RVMD) over the last 6 years, with Dec 2024 value amounting to -$1.7 billion.

  • Revolution Medicines' Retained Earnings fell 62.27% to -$2.5 billion in Q3 2025 from the same period last year, while for Sep 2025 it was -$2.5 billion, marking a year-over-year decrease of 62.27%. This contributed to the annual value of -$1.7 billion for FY2024, which is 52.75% down from last year.
  • As of FY2024, Revolution Medicines' Retained Earnings stood at -$1.7 billion, which was down 52.75% from -$1.1 billion recorded in FY2023.
  • Revolution Medicines' 5-year Retained Earnings high stood at -$265.5 million for FY2020, and its period low was -$1.7 billion during FY2024.
  • In the last 3 years, Revolution Medicines' Retained Earnings had a median value of -$1.1 billion in 2023 and averaged -$1.2 billion.
  • Data for Revolution Medicines' Retained Earnings shows a maximum YoY plummeted of 70.46% (in 2021) over the last 5 years.
  • Over the past 5 years, Revolution Medicines' Retained Earnings (Yearly) stood at -$265.5 million in 2020, then crashed by 70.46% to -$452.6 million in 2021, then tumbled by 54.95% to -$701.3 million in 2022, then tumbled by 62.22% to -$1.1 billion in 2023, then slumped by 52.75% to -$1.7 billion in 2024.